AstraZeneca PLC (ZEG.DE)
EUR 126.0
(-1.41%)
EUR 126.0
(-1.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 45.81 Billion | 44.35 Billion | 37.41 Billion | 26.61 Billion | 24.38 Billion | 22.09 Billion |
| Cost of Revenue | 8.26 Billion | 12.39 Billion | 12.43 Billion | 5.29 Billion | 4.92 Billion | 4.93 Billion |
| Gross Profit | 37.54 Billion | 31.96 Billion | 24.98 Billion | 21.31 Billion | 19.46 Billion | 17.15 Billion |
| Operating Expenses | 29.57 Billion | 28.2 Billion | 23.92 Billion | 16.15 Billion | 16.26 Billion | 13.76 Billion |
| Selling, General and Administrative Expenses | 18.02 Billion | 18.95 Billion | 15.68 Billion | 11.69 Billion | 11.84 Billion | 10.36 Billion |
| Research and Development Expenses | 11.01 Billion | 9.76 Billion | 9.73 Billion | 5.99 Billion | 5.95 Billion | 5.93 Billion |
| Other Expenses | 538 Million | -514 Million | -1.49 Billion | -1.52 Billion | -1.54 Billion | -650 Million |
| Cost and Expenses | 37.61 Billion | 40.59 Billion | 36.36 Billion | 21.45 Billion | 21.18 Billion | 18.7 Billion |
| Operating Income | 8.19 Billion | 3.75 Billion | 1.05 Billion | 5.16 Billion | 2.92 Billion | 3.38 Billion |
| Interest Expense | 1.58 Billion | 1.34 Billion | 1.3 Billion | 1.3 Billion | 1.43 Billion | 1.41 Billion |
| Income Tax Expense | 938 Million | -792 Million | -380 Million | 772 Million | 321 Million | -57 Million |
| Earnings before Tax | 6.89 Billion | 2.5 Billion | -265 Million | 3.91 Billion | 1.54 Billion | 1.99 Billion |
| Net Income | 5.95 Billion | 3.28 Billion | 112 Million | 3.19 Billion | 1.33 Billion | 2.15 Billion |
| Earnings Per Share Basic | 3.81 | 2.12 | 0.08 | 2.44 | 1.03 | 1.70 |
| Earnings Per Share Diluted | 3.81 | 2.11 | 0.08 | 2.44 | 1.03 | 1.70 |
| Weighted Average Shares Outstanding | 1.56 Billion | 1.54 Billion | 1.41 Billion | 1.31 Billion | 1.3 Billion | 1.26 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.56 Billion | 1.56 Billion | 1.42 Billion | 1.31 Billion | 1.3 Billion | 1.26 Billion |
| Gross Margin | 0.82 | 0.72 | 0.67 | 0.80 | 0.80 | 0.78 |
| EBIT Margin | 0.29 | 0.21 | 0.20 | 0.31 | 0.29 | 0.32 |
| Profit Margin | 0.13 | 0.07 | 0.00 | 0.12 | 0.05 | 0.10 |
| EBITDA | 13.42 Billion | 9.08 Billion | 5.11 Billion | 8.08 Billion | 6.71 Billion | 7.11 Billion |
| Earnings Before Tax Margin | 0.18 | 0.08 | 0.03 | 0.19 | 0.12 | 0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 12.93 Billion | 12.67 Billion | 45.81 Billion | 12.02 Billion | 11.49 Billion | 11.41 Billion |
| Cost of Revenue | 2.18 Billion | 2.21 Billion | 8.26 Billion | 2.3 Billion | 2.09 Billion | 1.96 Billion |
| Gross Profit | 10.75 Billion | 10.46 Billion | 37.54 Billion | 9.71 Billion | 9.39 Billion | 9.45 Billion |
| Operating Expenses | 8 Billion | 7.34 Billion | 28.82 Billion | 7.71 Billion | 7.44 Billion | 7 Billion |
| Selling, General and Administrative Expenses | 5.06 Billion | 4.63 Billion | - | 3.98 Billion | 4.92 Billion | 5.11 Billion |
| Research and Development Expenses | 3 Billion | 2.78 Billion | - | 3.07 Billion | 2.58 Billion | 2.66 Billion |
| Other Expenses | -3 Million | - | - | - | - | - |
| Cost and Expenses | 10.19 Billion | 9.56 Billion | 37.08 Billion | 10.02 Billion | 9.53 Billion | 8.96 Billion |
| Operating Income | 2.74 Billion | 3.11 Billion | 8.19 Billion | 1.23 Billion | 1.95 Billion | 2.45 Billion |
| Interest Expense | 443 Million | 413 Million | 1.58 Billion | 408 Million | 392 Million | 431 Million |
| Income Tax Expense | 469 Million | 620 Million | 938 Million | -62 Million | 274 Million | 268 Million |
| Earnings before Tax | 2.39 Billion | 2.8 Billion | 6.89 Billion | 897 Million | 1.65 Billion | 2.08 Billion |
| Net Income | 1.92 Billion | 2.17 Billion | 5.95 Billion | 960 Million | 1.37 Billion | 1.81 Billion |
| Earnings Per Share Basic | 1.24 | 1.41 | - | 0.62 | 0.89 | 1.17 |
| Earnings Per Share Diluted | 1.24 | 1.40 | - | 0.61 | 0.88 | 1.17 |
| Weighted Average Shares Outstanding | 1.55 Billion | 1.54 Billion | 1.54 Billion | 1.56 Billion | 1.54 Billion | 1.55 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.56 Billion | 1.56 Billion | 1.56 Billion | 1.56 Billion | 1.56 Billion | 1.56 Billion |
| Gross Margin | 0.83 | 0.83 | 0.82 | 0.81 | 0.82 | 0.83 |
| EBIT Margin | 0.32 | 0.35 | - | 0.24 | 0.29 | 0.22 |
| Profit Margin | 0.15 | 0.17 | 0.13 | 0.08 | 0.12 | 0.16 |
| EBITDA | 4.11 Billion | 4.46 Billion | - | 2.9 Billion | 3.32 Billion | 2.51 Billion |
| Earnings Before Tax Margin | 0.21 | 0.25 | 0.18 | 0.10 | 0.17 | 0.22 |
603668
OXBRW
CHL
8311
GICRE
AECFF